Author
Listed:
- Huilin Huang
(Beckman Research Institute of City of Hope
University of Cincinnati College of Medicine)
- Hengyou Weng
(Beckman Research Institute of City of Hope
University of Cincinnati College of Medicine)
- Keren Zhou
(Sun Yat-sen University
Sun Yat-sen University)
- Tong Wu
(University of Chicago
University of Chicago
University of Chicago
University of Chicago)
- Boxuan Simen Zhao
(University of Chicago
University of Chicago
University of Chicago
University of Chicago)
- Mingli Sun
(Beckman Research Institute of City of Hope
School of Pharmacy, China Medical University)
- Zhenhua Chen
(Beckman Research Institute of City of Hope)
- Xiaolan Deng
(Beckman Research Institute of City of Hope
University of Cincinnati College of Medicine
School of Pharmacy, China Medical University)
- Gang Xiao
(Beckman Research Institute of City of Hope)
- Franziska Auer
(Beckman Research Institute of City of Hope)
- Lars Klemm
(Beckman Research Institute of City of Hope)
- Huizhe Wu
(Beckman Research Institute of City of Hope
University of Cincinnati College of Medicine
School of Pharmacy, China Medical University)
- Zhixiang Zuo
(University of Cincinnati College of Medicine
Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine)
- Xi Qin
(Beckman Research Institute of City of Hope
University of Cincinnati College of Medicine)
- Yunzhu Dong
(Cincinnati Children’s Hospital Medical Center
Division of Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center)
- Yile Zhou
(Cincinnati Children’s Hospital Medical Center
Division of Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center)
- Hanjun Qin
(Beckman Research Institute of City of Hope)
- Shu Tao
(Beckman Research Institute of City of Hope)
- Juan Du
(Beckman Research Institute of City of Hope)
- Jun Liu
(University of Chicago
University of Chicago
University of Chicago
University of Chicago)
- Zhike Lu
(University of Chicago
University of Chicago
University of Chicago
University of Chicago)
- Hang Yin
(University of Chicago
University of Chicago
University of Chicago
University of Chicago)
- Ana Mesquita
(University of Cincinnati College of Medicine)
- Celvie L. Yuan
(Cincinnati Children’s Hospital Medical Center)
- Yueh-Chiang Hu
(Cincinnati Children’s Hospital Medical Center)
- Wenju Sun
(Sun Yat-sen University
Sun Yat-sen University)
- Rui Su
(Beckman Research Institute of City of Hope
University of Cincinnati College of Medicine)
- Lei Dong
(Beckman Research Institute of City of Hope
University of Cincinnati College of Medicine)
- Chao Shen
(Beckman Research Institute of City of Hope
University of Cincinnati College of Medicine)
- Chenying Li
(Beckman Research Institute of City of Hope
University of Cincinnati College of Medicine)
- Ying Qing
(Beckman Research Institute of City of Hope
University of Cincinnati College of Medicine)
- Xi Jiang
(Beckman Research Institute of City of Hope
University of Cincinnati College of Medicine
Zhejiang University School of Medicine
Zhejiang University & Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy)
- Xiwei Wu
(Beckman Research Institute of City of Hope)
- Miao Sun
(University of Cincinnati College of Medicine
Cincinnati Children’s Hospital Medical Center)
- Jun-Lin Guan
(University of Cincinnati College of Medicine)
- Lianghu Qu
(Sun Yat-sen University
Sun Yat-sen University)
- Minjie Wei
(School of Pharmacy, China Medical University)
- Markus Müschen
(Beckman Research Institute of City of Hope)
- Gang Huang
(Cincinnati Children’s Hospital Medical Center
Division of Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center)
- Chuan He
(University of Chicago
University of Chicago
University of Chicago
University of Chicago)
- Jianhua Yang
(Sun Yat-sen University
Sun Yat-sen University)
- Jianjun Chen
(Beckman Research Institute of City of Hope
University of Cincinnati College of Medicine)
Abstract
DNA and histone modifications have notable effects on gene expression1. Being the most prevalent internal modification in mRNA, the N6-methyladenosine (m6A) mRNA modification is as an important post-transcriptional mechanism of gene regulation2–4 and has crucial roles in various normal and pathological processes5–12. However, it is unclear how m6A is specifically and dynamically deposited in the transcriptome. Here we report that histone H3 trimethylation at Lys36 (H3K36me3), a marker for transcription elongation, guides m6A deposition globally. We show that m6A modifications are enriched in the vicinity of H3K36me3 peaks, and are reduced globally when cellular H3K36me3 is depleted. Mechanistically, H3K36me3 is recognized and bound directly by METTL14, a crucial component of the m6A methyltransferase complex (MTC), which in turn facilitates the binding of the m6A MTC to adjacent RNA polymerase II, thereby delivering the m6A MTC to actively transcribed nascent RNAs to deposit m6A co-transcriptionally. In mouse embryonic stem cells, phenocopying METTL14 knockdown, H3K36me3 depletion also markedly reduces m6A abundance transcriptome-wide and in pluripotency transcripts, resulting in increased cell stemness. Collectively, our studies reveal the important roles of H3K36me3 and METTL14 in determining specific and dynamic deposition of m6A in mRNA, and uncover another layer of gene expression regulation that involves crosstalk between histone modification and RNA methylation.
Suggested Citation
Huilin Huang & Hengyou Weng & Keren Zhou & Tong Wu & Boxuan Simen Zhao & Mingli Sun & Zhenhua Chen & Xiaolan Deng & Gang Xiao & Franziska Auer & Lars Klemm & Huizhe Wu & Zhixiang Zuo & Xi Qin & Yunzhu, 2019.
"Histone H3 trimethylation at lysine 36 guides m6A RNA modification co-transcriptionally,"
Nature, Nature, vol. 567(7748), pages 414-419, March.
Handle:
RePEc:nat:nature:v:567:y:2019:i:7748:d:10.1038_s41586-019-1016-7
DOI: 10.1038/s41586-019-1016-7
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Yuanpei Li & Xiaoniu He & Xiao Lu & Zhicheng Gong & Qing Li & Lei Zhang & Ronghui Yang & Chengyi Wu & Jialiang Huang & Jiancheng Ding & Yaohui He & Wen Liu & Ceshi Chen & Bin Cao & Dawang Zhou & Yufen, 2022.
"METTL3 acetylation impedes cancer metastasis via fine-tuning its nuclear and cytosolic functions,"
Nature Communications, Nature, vol. 13(1), pages 1-23, December.
- Yanjun Zhang & Yuan Fang & Yin Tang & Shixun Han & Junqi Jia & Xinyi Wan & Jiaqi Chen & Ying Yuan & Bin Zhao & Dong Fang, 2022.
"SMYD5 catalyzes histone H3 lysine 36 trimethylation at promoters,"
Nature Communications, Nature, vol. 13(1), pages 1-19, December.
- Chirag Nepal & Jesper B. Andersen, 2023.
"Alternative promoters in CpG depleted regions are prevalently associated with epigenetic misregulation of liver cancer transcriptomes,"
Nature Communications, Nature, vol. 14(1), pages 1-14, December.
- Yanfen Zheng & Xingyang Li & Shuang Deng & Hongzhe Zhao & Ying Ye & Shaoping Zhang & Xudong Huang & Ruihong Bai & Lisha Zhuang & Quanbo Zhou & Mei Li & Jiachun Su & Rui Li & Xiaoqiong Bao & Lingxing Z, 2023.
"CSTF2 mediated mRNA N6-methyladenosine modification drives pancreatic ductal adenocarcinoma m6A subtypes,"
Nature Communications, Nature, vol. 14(1), pages 1-17, December.
- Xin Yang & Robinson Triboulet & Qi Liu & Erdem Sendinc & Richard I. Gregory, 2022.
"Exon junction complex shapes the m6A epitranscriptome,"
Nature Communications, Nature, vol. 13(1), pages 1-12, December.
- Yongli Shan & Yanqi Zhang & Yanxing Wei & Cong Zhang & Huaisong Lin & Jiangping He & Junwei Wang & Wenjing Guo & Heying Li & Qianyu Chen & Tiancheng Zhou & Qi Xing & Yancai Liu & Jiekai Chen & Guangji, 2024.
"METTL3/METTL14 maintain human nucleoli integrity by mediating SUV39H1/H2 degradation,"
Nature Communications, Nature, vol. 15(1), pages 1-13, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:567:y:2019:i:7748:d:10.1038_s41586-019-1016-7. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.